ACE and hydrops fetalis: Following variables were also associated with death or cardiac transplantation: de novo HF (P < 0.001), non‐use of angiotensin‐converting enzyme inhibitor or angiotensin II inhibitor use (P = 0.041), non‐use of cardiac resynchronization therapy use (P = 0.038), age (P = 0.015), and LVEF (P = 0.032).